Concepedia

Shangeng Weng

SW

Statistics

Publications

9

Citations

243

H-Index

9

Active since

2006

Affiliations

Fujian Medical University(Current)

First Affiliated Hospital of Fujian Medical University

Fujian Provincial Hospital

Shangeng Weng is an author at Fujian Medical University specializing in medicine, pancreatic cancer, and oncology.

Publications per year

2006–2024

9

Publications

9

N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway

Chengjie Lin, Yan Wang, Yihong Dong et al. · Biology Direct · 2022 · 41 citations · Full text

Medicine, Cancer Biology, Oncology +17

METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation

Chengjie Lin, Ting Li, Yan Wang et al. · Cell Death and Disease · 2023 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +17

METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification

Zhenyun Guo, Xiang Zhang, Chengjie Lin et al. · Frontiers in Oncology · 2022 · 36 citations · Full text

Medicine, Molecular Biology, Oncology +16

N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer

Shihui Lai, Yan Wang, Ting Li et al. · Cell & Bioscience · 2022 · 34 citations · Full text

Medicine, Molecular Biology, Oncology +16

Global burden of adult non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has been steadily increasing over the past decades and is expected to persist in the future

Xuan Dong, Jing-Mao Li, Xiaoling Lü et al. · Translational Gastroenterology and Hepatology · 2024 · 33 citations · Full text

Medicine, Health Sciences, Epidemiologic Methods +14

1–5 of 9